Immunosuppressant EQA | 合法醫療器材資訊網

RIQAS is the worlds largest external Quality Assessment with over 50000 participants. Our current EQA portfolio has 33 programme options. Read More

The RIQAS General Clinical Chemistry EQA programme is designed to monitor the performance of up to 56 parameters covering routine chemistries, lipids, ... Read More

The RIQAS Immunoassay EQA programme is designed to monitor the performance of up to 51 immunoassay parameters including therapeutic drugs; hormones ... Read More

The RIQAS Immunosuppressant EQA programme has been designed to cover the analysis of Immunosuppressants in clinical laboratories. Read More

Randox offers RIQAS, the largest EQA scheme in the world with over 45,000 participants across 133 countries, offering 33 consolidated programmes. Randox also ... Read More

Following on from the success of the QCMD 2021 Coronavirus Outbreak Preparedness EQA Pilot Study, Randox is pleased to announce two new QCMD EQA ... Read More

The RIQAS Urinalysis EQA programme is designed to monitor the performance of urine dipstick test using both manual and automated methods. Read More

Overview; New Programmes; Cardiac Plus; RIQAS Point-of-Care. QC & EQA. A world leading provider of quality control material. Reagents. Extensive range of ... Read More

RIQASNet - assess the analytical performance of a laboratory compared to ... Read More